跳至主要内容
临床试验/NCT02104921
NCT02104921已完成不适用

Innovative Ultrasound Technology in Neuromuscular Disease

Beth Israel Deaconess Medical Center1 个研究点 分布在 1 个国家目标入组 223 人开始时间: 2013年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
223
试验地点
1
主要终点
Quantitative ultrasound data, including quantified grayscale data and backscattered acoustic data

研究概览

简要总结

This study is utilizing ultrasound measurement to measure neuromuscular disease status in adult patients. The hypothesis is the by quantifying ultrasound data, it is possible that ultrasound can be utilized as a tool to determine if a disease is responding to therapy or progressing.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • History of a well-defined, localized or generalized neuromuscular condition producing weakness or muscle atrophy, including disuse atrophy.

排除标准

  • Multiple generalized neuromuscular conditions.

结局指标

主要结局

Quantitative ultrasound data, including quantified grayscale data and backscattered acoustic data

时间窗: 1 year

Ultrasound data will be collected on multiple muscles in each person. The images will then be quantified using either 1. A grayscale technique in which the images themselves are analyzed via standard image software (e.g., Adobe Photoshop) as to level of echo intensity in a pre-specific region of interest or 2. the raw quantified backscatter data is captured by the transducer, expressed as a unit of power, in the same pre-specified area of interest

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Seward Rutkove

Professor of Neurology

Beth Israel Deaconess Medical Center

研究点 (1)

Loading locations...

相似试验